Skip to main content

Recognition of human tumors: SEREX expression cloning to identify tumour antigens

  • Chapter

Part of the book series: Immunology and Medicine Series ((IMME,volume 30))

Abstract

The search for tumor antigens which are able to elicit specific immune responses in the tumor-bearing host is one of the cardinal quests in tumor immunology. The knowledge of their molecular nature provides us not only with potential targets for immunotherapeutic interventions against neoplastic cells, but also provides us with new disease markers and new insights into the molecular mechanisms of malignant transformation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maloney DG, GrilloLopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, and Levy R, IDEC-C2B8 (Rituximab) antiCD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma Blood, 1997; 90: 2188–2195.

    CAS  Google Scholar 

  2. Old LJ, Cancer Immunology–the Search for Specificity–Clowes,G.H.A. Memorial Lecture. Cancer Res, 1981; 41: 361–375.

    PubMed  CAS  Google Scholar 

  3. van der Bruggen P, Traversari C, Chomez P, Lurquin C, Deplaen E, van den Eynde B, Knuth A, and Boon T, A gene encoding an antigen recognized by cytolytic lymphocytes-t on a human-melanoma Science, 1991; 254: 1643–1647.

    Google Scholar 

  4. Sah in U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo GR, Schobert 1, and Pfreundschuh M, Human Neoplasms Elicit Multiple Specific Immune-Responses In the Autologous Host. Proc Natl Acad Sci USA, 1995; 92: 11810–11813.

    Article  Google Scholar 

  5. Rotzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, and Rammensee HG, Isolation and Analysis of Naturally Processed Viral Peptides as Recognized by Cytotoxic T-Cells. Nature, 1990; 348: 252–254.

    Article  PubMed  CAS  Google Scholar 

  6. Boon T, Coulie PG, and Van den Eynde B, Tumor antigens recognized by T cells. Immunol Today, 1997; 18: 267–268.

    Article  PubMed  CAS  Google Scholar 

  7. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, and Goodnow CC, Elimination of Self-Reactive Lymphocytes-B Proceeds in 2 Stages–Arrested Development and Cell-Death. Cell, 1993; 72: 325–335.

    Article  PubMed  CAS  Google Scholar 

  8. Sahin U, Tureci O, and Pfreundschuh M, Serological identification of human tumor antigens. Curr Opin Immunol, 1997; 9: 709–716.

    Article  PubMed  CAS  Google Scholar 

  9. Tureci O, Sahin U, and Pfreundschuh M, Serological analysis of human tumor antigens: Molecular definition and implications. Mol Med Today, 1997; 3: 342–349.

    Article  PubMed  CAS  Google Scholar 

  10. Tureci O, Sahin U, Zwick C, Neumann F, and Pfreundschuh M, Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma, 1999; 18: 23–28.

    Article  PubMed  CAS  Google Scholar 

  11. Tureci O, Schmitt H, Fadle N, Pfreundschuh M, and Sahin U, Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin’s disease. J Biol Chem, 1997; 272: 6416–6422.

    Article  PubMed  CAS  Google Scholar 

  12. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, and Old LJ, Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A, 1998; 95: 6919–6923.

    Article  PubMed  CAS  Google Scholar 

  13. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, and Meese E, Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma Hum Mol Genet, 1997; 6: 33–39.

    CAS  Google Scholar 

  14. Rosenberg SA, A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity, 1999; 10: 281–287.

    Article  PubMed  CAS  Google Scholar 

  15. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmannhieb E, Deplaen E, Hankeln T, Zumbuschenfelde KHM, and Beach D, A P16(Ink4a)-Insensitive Cdk4 Mutant Targeted by Cytolytic T- Lymphocytes in a Human-Melanoma Science, 1995; 269: 1281–1284.

    CAS  Google Scholar 

  16. Wang RF, Wang X, Atwood AC, Topalian SL, and Rosenberg SA, Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen. Science, 1999; 284: 1351–1354.

    Article  PubMed  CAS  Google Scholar 

  17. Tureci O, Sahin U, Vollmar E, Siemer S, Gotten E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, and Sly WS, Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A, 1998; 95: 7608–7613.

    Article  PubMed  CAS  Google Scholar 

  18. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, and Old LJ, Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer, 1998; 76: 652–658.

    Article  PubMed  CAS  Google Scholar 

  19. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, and Lerman MI, Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A, 1998; 95: 12596–12601.

    Article  PubMed  CAS  Google Scholar 

  20. Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, Pastorek J, and Sly WS, Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci U S A, 2000; 97: 2220–2224.

    Article  PubMed  CAS  Google Scholar 

  21. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, and Pfreundschuh M, Identification of a meiosisspecific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA, 1998; 95: 5211–5216.

    Article  PubMed  CAS  Google Scholar 

  22. Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, and Old U, A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med, 1998; 187: 1349–1354.

    Article  PubMed  CAS  Google Scholar 

  23. Rammensee HG, Friede T, and Stevanovic S, MHC Ligands and Peptide Motifs–First Listing. Immunogenetics, 1995; 41: 178–228.

    Article  PubMed  CAS  Google Scholar 

  24. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, and Sinigaglia F, Precise prediction of major histocompatibility complex class-ii peptide interaction based on peptide side-chain scanning. J Exp Med, 1994; 180: 2353–2358.

    Article  PubMed  CAS  Google Scholar 

  25. Boczkowski D, Nair SK, Snyder D, and Gilboa E, Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med, 1996; 184: 465–472.

    Article  PubMed  CAS  Google Scholar 

  26. Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, Moore MAS, and Crystal RG, Dendritic cells genetically modified with an adenovirus vector encoding the eDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med, 1997; 186: 1247–1256.

    Article  PubMed  CAS  Google Scholar 

  27. Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, and Restifo NP, Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci U S A, 1997; 94: 3183–3188.

    Article  PubMed  CAS  Google Scholar 

  28. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, and van der Bruggen P, Bage–a New Gene Encoding an Antigen Recognized on Human Melanomas by Cytolytic T-Lymphocytes. Immunity, 1995; 2: 167–175.

    Article  PubMed  CAS  Google Scholar 

  29. van den Eynde B, Peeters O, Debacker O, Gaugler B, Lucas S, and Boon T, A New Family Of Genes-Coding For an Antigen Recognized By Autologous Cytolytic T-Lymphocytes On a Human-Melanoma 1 Exp Med, 1995; 182: 689–698.

    Google Scholar 

  30. Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, and Pfreundschuh M, The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res, 1996; 56: 4766–4772.

    PubMed  CAS  Google Scholar 

  31. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, and Cooper CS, Identification of Novel Genes, Syt and Ssx, Involved in the T(X18)(P11.2q11.2) Translocation Found in Human Synovial Sarcoma Nat Genet, 1994; 7: 502–508.

    CAS  Google Scholar 

  32. Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, and Chen YT, SSX: A multigene family with several members transcribed in normal testis and human cancer. Int J Cancer, 1997; 72: 965–971.

    Article  PubMed  CAS  Google Scholar 

  33. Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, and Pfreundschuh M, Expression of SSX genes in human tumors. Int J Cancer, 1998; 77: 19–23.

    Article  PubMed  CAS  Google Scholar 

  34. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang SL, Williamson B, Stockert E, Pfreundschuh M, and Old LJ, A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA, 1997; 94: 1914–1918.

    Article  PubMed  CAS  Google Scholar 

  35. Lethe B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, and Boon T, LAGE-1, a new gene with tumor specificity. Int J Cancer, 1998; 76: 903–908.

    Article  PubMed  CAS  Google Scholar 

  36. Jager E, Chen YT, Drijthout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, and Knuth A, Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med, 1998; 187: 265–270.

    Article  PubMed  CAS  Google Scholar 

  37. Aarnoudse CA, van den Doel PB, Heemskerk B, and Schrier PI, Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product of LAGE-1. Int J Cancer, 1999; 82: 442–448.

    Article  PubMed  CAS  Google Scholar 

  38. Wang RF, Johnston SL, Zeng G, Topalian SL, Schwartzentruber DJ, and Rosenberg SA, A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J Immunol, 1998; 161: 3596–3606.

    CAS  Google Scholar 

  39. Jager E, Stockert E, Zidianakis Z, Chen YT, Karbach J, Jager D, Arand M, Ritter G, Old LJ, and Knuth A, Humoral immune responses of cancer patients against “Cancer- Testis” antigen NY-ESO-1: Correlation with clinical events. Int J Cancer, 1999; 84: 506–510.

    Article  PubMed  CAS  Google Scholar 

  40. Meuwissen RLJ, Meerts I, Hoovers JMN, Leschot NJ, and Heyting C, Human synaptonemal complex protein 1 (SCP1): Isolation and characterization of the cDNA and chromosomal localization of the gene. Genomics, 1997; 39: 377–384.

    Article  PubMed  CAS  Google Scholar 

  41. Old LJ and Chen YT, New paths in human cancer serology. J Exp Med, 1998; 187: 1163–1167.

    Article  PubMed  CAS  Google Scholar 

  42. Sabin U, Tureci O, Chen YT, Seitz G, Villena-Heinsen C, Old LJ, and Pfreundschuh M, Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer, 1998; 78: 387–389.

    Article  Google Scholar 

  43. Hofbauer GFL, Schaefer C, Noppen C, Boni R, Kamarashev J, Nestle FO, Spagnoli GC, and Dummer R, MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma–Frequency and distribution. Am J Pathol, 1997; 151: 1549–1553.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Sahin, U., Li, G., Türeci, Ö., Pfreundschuh, M. (2001). Recognition of human tumors: SEREX expression cloning to identify tumour antigens. In: Robins, R.A., Rees, R.C. (eds) Cancer Immunology. Immunology and Medicine Series, vol 30. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0963-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0963-7_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5714-3

  • Online ISBN: 978-94-017-0963-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics